Suppr超能文献

诊断因人而异:印度儿童黏多糖贮积症早期诊断的障碍

Diagnosis is in the Eye of the Beholder: Barriers to Early Diagnosis of Mucopolysaccharidosis in Children in India.

作者信息

Grewal Meenu, Muranjan Mamta

机构信息

Department of Pediatrics, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Parel, Mumbai, Maharashtra, India.

出版信息

J Pediatr Genet. 2020 Sep 18;10(4):300-304. doi: 10.1055/s-0040-1716707. eCollection 2021 Dec.

Abstract

The present study examined referral pattern and diagnostic practices for mucopolysaccharidosis (MPS) in India in 40 patients with a confirmed diagnosis. Time lag between age of onset of symptoms and consultation with primary physician ranged from 0 to 84 months, between consultation with primary physician and visit to genetic clinic of 0 to 128 months, from visit to genetic clinic and diagnosis of 1 to 111 months, and that between onset of symptoms and diagnosis 1 to 154 months. Major causes for delayed diagnosis were symptoms overlooked by physician (54%), late consultation by care giver (48.6%), late onset of symptoms (43.2%), and resource crunch (32.4%). Diagnosis at referral other than MPS was noted in 45%. Thus, diagnostic delay for MPS is common due to health seeking practices of parents, as well as physicians' clinical practices. Overcoming these barriers would necessitate strengthening awareness and educational activities for physicians and lay public.

摘要

本研究调查了印度40例确诊为黏多糖贮积症(MPS)患者的转诊模式和诊断方法。症状出现年龄与初次咨询医生之间的时间间隔为0至84个月,初次咨询医生与前往基因诊所就诊之间的时间间隔为0至128个月,从前往基因诊所就诊到确诊的时间间隔为1至111个月,症状出现到确诊的时间间隔为1至154个月。诊断延迟的主要原因是医生忽略症状(54%)、照顾者咨询延迟(48.6%)、症状出现较晚(43.2%)和资源短缺(32.4%)。45%的转诊诊断并非MPS。因此,由于家长的就医习惯以及医生的临床诊疗行为,MPS的诊断延迟很常见。克服这些障碍需要加强针对医生和普通公众的宣传和教育活动。

相似文献

1
Diagnosis is in the Eye of the Beholder: Barriers to Early Diagnosis of Mucopolysaccharidosis in Children in India.
J Pediatr Genet. 2020 Sep 18;10(4):300-304. doi: 10.1055/s-0040-1716707. eCollection 2021 Dec.
4
The diagnostic journey of patients with mucopolysaccharidosis I: A real-world survey of patient and physician experiences.
Mol Genet Metab Rep. 2016 Aug 2;8:67-73. doi: 10.1016/j.ymgmr.2016.07.006. eCollection 2016 Sep.
5
Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII - a European caregiver survey.
Orphanet J Rare Dis. 2019 Nov 14;14(1):254. doi: 10.1186/s13023-019-1233-z.
6
Ocular features in mucopolysaccharidosis: diagnosis and treatment.
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):125. doi: 10.1186/s13052-018-0559-9.
7
Eye movement disorders and neurological symptoms in late-onset inborn errors of metabolism.
Mov Disord. 2018 Dec;33(12):1844-1856. doi: 10.1002/mds.27484. Epub 2018 Nov 28.
8
Current diagnosis and management of mucopolysaccharidosis VI in the Asia-Pacific region.
Mol Genet Metab. 2012 Sep;107(1-2):136-44. doi: 10.1016/j.ymgme.2012.07.019. Epub 2012 Jul 20.
9
Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis.
Rheumatol Int. 2011 May;31(5):657-65. doi: 10.1007/s00296-009-1358-9. Epub 2010 Jan 12.
10
Identifying the need for a multidisciplinary approach for early recognition of mucopolysaccharidosis VI (MPS VI).
Mol Genet Metab. 2015 May;115(1):41-7. doi: 10.1016/j.ymgme.2015.03.005. Epub 2015 Mar 26.

引用本文的文献

1
Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in China.
Orphanet J Rare Dis. 2024 Sep 6;19(1):324. doi: 10.1186/s13023-024-03333-4.
2
Lysosomal storage disorders: from biology to the clinic with reference to India.
Lancet Reg Health Southeast Asia. 2022 Nov 21;9:100108. doi: 10.1016/j.lansea.2022.100108. eCollection 2023 Feb.
3
Misdiagnosis in mucopolysaccharidoses.
J Appl Genet. 2022 Sep;63(3):475-495. doi: 10.1007/s13353-022-00703-1. Epub 2022 May 13.

本文引用的文献

2
Diagnosis of Morquio-A patients in Mexico: How far are we from prompt diagnosis?
Intractable Rare Dis Res. 2017 May;6(2):119-123. doi: 10.5582/irdr.2017.01016.
3
Early disease progression of Hurler syndrome.
Orphanet J Rare Dis. 2017 Feb 14;12(1):32. doi: 10.1186/s13023-017-0583-7.
4
The diagnostic journey of patients with mucopolysaccharidosis I: A real-world survey of patient and physician experiences.
Mol Genet Metab Rep. 2016 Aug 2;8:67-73. doi: 10.1016/j.ymgmr.2016.07.006. eCollection 2016 Sep.
5
Mucopolysaccharidosis type I disguised as rickets.
BMJ Case Rep. 2016 May 11;2016:bcr2016215416. doi: 10.1136/bcr-2016-215416.
6
Overcoming the barriers to diagnosis of Morquio A syndrome.
Orphanet J Rare Dis. 2014 Nov 30;9:192. doi: 10.1186/s13023-014-0192-7.
7
The relative frequency of lysosomal storage disorders: a medical genetics referral laboratory's experience from India.
J Child Neurol. 2014 Oct;29(10):1377-82. doi: 10.1177/0883073813515075. Epub 2014 Apr 2.
8
The natural history of MPS I: global perspectives from the MPS I Registry.
Genet Med. 2014 Oct;16(10):759-65. doi: 10.1038/gim.2014.25. Epub 2014 Mar 27.
10
Mucopolysacccharidoses: From understanding to treatment, a century of discoveries.
Genet Mol Biol. 2012 Dec;35(4 (suppl)):924-31. doi: 10.1590/s1415-47572012000600006. Epub 2012 Dec 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验